Incentives boost compliance rates, study finds
NORWALK, Conn. — Looking to boost medication compliance rates for patients? Cash incentives and interactive games might be a key.
That’s the finding from HealthPrize Technologies, a Web-based software company that conducted a feasibility study gauging how incentives and games can assist in increasing medication compliance. The company found that average compliance rates for patients given those incentives was 88%.
“The results overwhelmingly showed that people are highly likely to stick with their medication regimens if they are rewarded for doing so, and if the program is engaging and fun,” noted HealthPrize. The one-month study was conducted on the company’s online platform.
The 88% adherence rate is significant, said a company representative, “considering that none of the subjects were lost to follow-up or otherwise excluded from analysis, a common occurrence in other adherence studies that often results in a bias toward artificially high compliance rates that are unrealistic in the real world,” the representative added.
HealthPrize engaged 20 subjects for the study. The patients registered online and engaged with Version 1.0 of the company’s online and mobile program for one month, reporting their compliance via the method of their choice (response to daily text or e-mail, or via their personal online HealthPrize dashboard or mobile application).
Participants earned points for self-reporting their compliance, engaging in weekly quizzes and surveys and “cracking open” daily educational “fortune cookies,” according to the company.
“Fun is not a word you hear in health care very often, and we’d like to change that,” said Katrina Firlik, co-founder and chief medical officer of HealthPrize. “The ‘Engagement Engine’ we’ve built is a comprehensive platform that leverages the combined power of incentives, education and reminders inspired by game dynamics and behavioral economics. Behavior change does not have to be a bitter pill.”
One participant, a long-time healthcare consultant, admitted that with HealthPrize he was more compliant with his medication, a statin, than he had ever been before, the company reported. “HealthPrize provided insights and facts about my condition and medication that I wasn’t aware of,” the participant said. “It helped to keep my medication top-of-mind, and it was fun earning points.”
BB&T rescinds mandatory mail Rx proposal, drawing praise from independent pharmacies
ALEXANDRIA, Va. — The nation’s top independent pharmacy group is hailing a recent decision by a major corporation to maintain freedom of choice of where its employees fill their maintenance prescription medicines.
The National Community Pharmacists Association today applauded BB&T’s decision to reemphasize and continue its employees’ choice in filling their maintenance prescriptions, including at independent community pharmacies. The revised policy was communicated to BB&T employees last week.
“Many small businesses, including independent pharmacies, have found BB&T to be a trusted business partner and ally of local enterprise,” said NCPA EVP and CEO Kathleen Jaeger. “We appreciate BB&T leadership taking this step, which will benefit its 30,000 employees, their families and their communities in 12 states. In return, independent pharmacists look forward to continuing to provide expert, personalized medication counseling and other cost-saving healthcare services to these patients."
In November, BB&T began notifying employees of a broad program utilizing a mandatory mail-order plan. In response, NCPA contacted BB&T to request reconsideration of the policy based on an alternative savings strategy. NCPA discussed the value of neighborhood pharmacies to local communities, detailed the often-overlooked shortcomings in mandatory mail-order plans and cost estimates and proposed such alternative cost-savings solutions as maximizing the appropriate use of generic drugs.
BB&T decided to keep its current program in place for maintenance prescriptions “to provide choice to employees and to show its support for local businesses,” NCPA noted.
“NCPA is proud to have shared an open dialogue and worked with BB&T to continue the current program,” Jaeger said. “We thank BB&T for listening to pharmacists’ concerns. Hopefully, other corporations will come to see the value of continuing their outreach to community pharmacists and supporting local businesses, particularly in today’s economy.”
Helling, Lutz re-elected to APhA Foundation
WASHINGTON — The APhA Foundation said Tuesday that it has re-elected two prominent pharmacy leaders to its board of directors. Dennis Helling and Eugene Lutz will be officially installed at the American Pharmacist Association’s 2011 Annual Meeting in Seattle on March 25 to 28.
Lutz, who served two terms on the APhA Board of Trustees and as president of APhA, is co-owner and president of Lutz Pharmacy and Lutz Long Term Care Pharmacy in Altoona, Iowa. He is past president of the Iowa Pharmacy Association and the American Pharmacists Association-Academy of Pharmacy Practice and Management. He also is active internationally and serves on the executive committee of the Community Pharmacy Section of Federation International Pharmacy. He has served on numerous local, state and national committees and as a member of the APhA House of Delegates since 1980.
Lutz’s pharmacy was 1-of-12 pilots in the development of the Iowa Center for Pharmaceutical care “re-engineering project.” He participated in the APhA Foundation’s Project ImPACT and several other projects designed to demonstrate the pharmacist’s role in medication management. His practice includes long-term care, compounding, lipid, asthma and diabetes management and immunizations.
Helling, who serves with numerous pharmacy organizations, is executive director of pharmacy operations and therapeutics for Kaiser Permanente in Denver, where he oversees more than 800 employees at 29 pharmacies and “influences the expansion of pharmacists’ roles and ambulatory clinical pharmacy services,” according to the APhA. He is a clinical professor with the University of Colorado School of Pharmacy and is VP of the board of directors for The Denver Hospice.
In his research and practice, Helling has documented the impact pharmacists have on improving patient outcomes and the costs of health care. He is the recipient of numerous awards and honors, including two Pinnacle Awards from the APhA Foundation’s Quality Center.